Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

GXYLT2 Inhibitors

GXYLT2 inhibitors are a class of chemical compounds that specifically target the enzymatic activity of glucoside xylosyltransferase 2 (GXYLT2), an enzyme involved in the post-translational modification of proteins. GXYLT2 plays a role in the addition of xylose residues to O-glucosylated serine or threonine residues within proteins, a modification that is part of the complex glycosylation pathway affecting various cellular processes. Inhibitors of GXYLT2 act by blocking this enzyme's ability to transfer xylose moieties, thereby impacting the glycosylation pattern of proteins. This alteration in glycosylation can influence protein stability, folding, and interactions within the cellular environment. The inhibition of GXYLT2 can provide insights into the biological pathways regulated by this specific glycosylation step and can be used to study the functional consequences of altered xylosylation on protein behavior.

Structurally, GXYLT2 inhibitors vary in their chemical compositions but generally contain moieties that interact with the active site of the enzyme, thereby preventing its action on substrate proteins. The binding affinity and specificity of these inhibitors depend on their structural compatibility with GXYLT2, which may include features such as aromatic rings, hydrogen bond donors/acceptors, and hydrophobic pockets that enhance the interaction with the enzyme's active site. The study of GXYLT2 inhibitors is important for understanding the detailed mechanisms of protein glycosylation and the role of GXYLT2 in cellular physiology. Additionally, these inhibitors are valuable as molecular tools in biochemical research to modulate and dissect the pathways involving protein glycosylation. Through the use of GXYLT2 inhibitors, researchers can explore the fundamental processes of protein modification and their subsequent effects on cellular functions, signaling pathways, and protein-protein interactions.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$99.00
$335.00
$836.00
$2099.00
47
(3)

DAPT is a γ-secretase inhibitor that can inhibit the Notch signaling pathway, potentially affecting processes related to GXYLT2.

Dibenzazepine (Deshydroxy LY 411575)

209984-56-5sc-207554
sc-207554A
2 mg
5 mg
$100.00
$260.00
4
(1)

LY411575 is another potent γ-secretase inhibitor, potentially impacting the Notch pathway and indirectly GXYLT2.

MK-0752

471905-41-6sc-364534
sc-364534A
10 mg
50 mg
$592.00
$1550.00
(1)

MK-0752, a γ-secretase inhibitor, might indirectly modulate Notch signaling and thus GXYLT2's role.

RO-4929097

847925-91-1sc-364602
sc-364602A
10 mg
50 mg
$430.00
$1389.00
1
(1)

RO4929097 inhibits γ-secretase, affecting Notch signaling and potentially influencing GXYLT2.

PF-3084014

1290543-63-3sc-507501
5 mg
$130.00
(0)

PF-03084014, another γ-secretase inhibitor, could indirectly affect processes where GXYLT2 is involved.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A disrupts Golgi apparatus function, which could influence the glycosylation processes involving GXYLT2.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, potentially impacting the glycosylation steps where GXYLT2 is involved.

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$135.00
$246.00
$619.00
$799.00
$1796.00
6
(1)

Swainsonine, an inhibitor of Golgi mannosidase II, might affect glycosylation processes relevant to GXYLT2's function.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$180.00
$620.00
10
(1)

Castanospermine, an alpha-glucosidase inhibitor, could impact the glycosylation steps in which GXYLT2 operates.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Decitabine, a DNA methyltransferase inhibitor, might indirectly affect GXYLT2 by altering gene expression.